Infographic | May 22, 2018

Benefits Of Using Preferred Providers For Clinical Development Outsourcing

Source: ISR Reports
ISR Reports

In Q1 2018, ISR surveyed 117 outsourcers at biopharmaceutical sponsors regarding the use and performance of a variety of clinical development outsourcing models. According to respondents using the Preferred Provider model, the most frequently experienced benefits of employing this model include Improved service provider relationships/deeper partnerships (mentioned by 60% of respondents) and Vendor consolidation (59% of respondents). The most oft-mentioned drawback is Lack of ultimate control (41% of respondents) with several others close behind.

VIEW THE INFOGRAPHIC!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online